Drug Type Small molecule drug |
Synonyms DN 1406131, DN-131, DN131 + [1] |
Target |
Mechanism IDO1 inhibitors(Indoleamine 2,3-dioxygenase inhibitors), TDO inhibitors(Tryptophan 2,3-dioxygenase inhibitors) |
Therapeutic Areas |
Active Indication- |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced Malignant Solid Neoplasm | Phase 1 | CN | 07 Sep 2018 | |
Advanced Malignant Solid Neoplasm | Phase 1 | CN | 07 Sep 2018 | |
Locally Advanced Lung Non-Small Cell Carcinoma | Phase 1 | CN | 07 Sep 2018 | |
Locally Advanced Lung Non-Small Cell Carcinoma | Phase 1 | CN | 07 Sep 2018 | |
Locally Advanced Melanoma | Phase 1 | CN | 07 Sep 2018 | |
Locally Advanced Melanoma | Phase 1 | CN | 07 Sep 2018 | |
Metastatic melanoma | Phase 1 | CN | 07 Sep 2018 | |
Metastatic melanoma | Phase 1 | CN | 07 Sep 2018 | |
metastatic non-small cell lung cancer | Phase 1 | CN | 07 Sep 2018 | |
metastatic non-small cell lung cancer | Phase 1 | CN | 07 Sep 2018 |